Vaxart, Inc.(VXRT)
Biotechnology
Infectious Disease Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | Watson W. Mark Director | Purchase | +10,000 | +8.06%134,125 | $0.65 | $6,530 | View SEC filing | |
| 2025-12-05 | Watson W. Mark Director | Purchase | +20,000 | +19.21%124,125 | $0.41 | $8,185 | View SEC filing | |
| 2025-11-21 | HERON ELAINE J Director | Purchase | +40,000 | +70.71%96,566 | $0.40 | $15,921 | View SEC filing | |
| 2025-08-19 | Finney Kevin Director | Purchase | +166,668 | +437.41%204,771 | $0.37 | $61,934 | View SEC filing | |
| 2025-07-31 | Watson W. Mark Director | Purchase | +10,000 | +10.62%104,125 | $0.41 | $4,050 | View SEC filing | |
| 2025-05-19 | Lo Steven President, Chief Exec Officer | Purchase | +100,000 | +100.00%100,000 | $0.49 | $49,000 | View SEC filing | |
| 2024-06-20 | Watson W. Mark Director | Purchase | +20,000 | +34.41%78,125 | $0.68 | $13,578 | View SEC filing | |
| 2022-12-28 | Watson W. Mark Director | Purchase | +20,000 | +100.00%20,000 | $0.76 | $15,140 | View SEC filing | |
| 2022-10-07 | Yedid Robert A. Director | Sale | -1,500 | -100.00%0 | $6.01 | $9,015 | View SEC filing | |
| 2022-06-23 | Ahmad Fuad Interim CFO | Purchase | +5,000 | +100.00%5,000 | $3.22 | $16,100 | View SEC filing | |
| 2021-12-01 | Echerd Margaret SVP, Principal Accntng Officer | Sale | -3,602 | -100.00%0 | $8.00 | $28,816 | View SEC filing | |
| 2021-09-13 | Echerd Margaret SVP, Principal Accntng Officer | Sale | -1,801 | -100.00%0 | $9.10 | $16,389 | View SEC filing | |
| 2021-08-11 | Tucker Sean SVP, Chief Scientific Officer | Sale | -10,000 | -9.49%95,346 | $10.20 | $102,000 | View SEC filing | |
| 2021-08-11 | Echerd Margaret SVP, Principal Accntng Officer | Sale | -1,801 | -100.00%0 | $10.00 | $18,010 | View SEC filing | |
| 2021-07-21 | Echerd Margaret SVP, Principal Accntng Officer | Sale | -1,800 | -100.00%0 | $8.00 | $14,400 | View SEC filing | |
| 2021-06-14 | Yedid Robert A. Director | Sale | -10,000 | -54.82%8,240 | $8.61 | $86,109 | View SEC filing | |
| 2021-06-14 | Echerd Margaret SVP, Principal Accntng Officer | Sale | -1,802 | -100.00%0 | $8.00 | $14,416 | View SEC filing | |
| 2021-06-11 | Echerd Margaret SVP, Principal Accntng Officer | Sale | -47,555 | -100.00%0 | $8.00 | $380,440 | View SEC filing | |
| 2021-05-10 | Latour Wouter Director | Sale | -200,000 | -100.00%0 | $6.83 | $1,366,640 | View SEC filing | |
| 2021-03-05 | Latour Wouter Director | Sale | -150,000 | -100.00%0 | $6.04 | $906,450 | View SEC filing | |
| 2020-11-23 | Latour Wouter Director | Sale | -333,334 | -100.00%0 | $6.32 | $2,108,138 | View SEC filing | |
| 2020-06-30 | ARMISTICE CAPITAL, LLC Director | Sale | -27,612,053 | -99.00%291,046 | $9.67 | $266,997,653 | View SEC filing | |
| 2020-06-03 | ARMISTICE CAPITAL, LLC Director | Sale | -1,400,000 | -15.66%14,000,000 | $2.75 | $3,856,000 | View SEC filing | |
| 2020-05-29 | ARMISTICE CAPITAL, LLC Director, 10% Owner | Sale | -200,000 | -1.18%16,800,000 | $2.61 | $522,000 | View SEC filing | |
| 2020-05-22 | ARMISTICE CAPITAL, LLC Director, 10% Owner | Sale | -1,750,000 | -12.02%17,200,000 | $3.10 | $5,428,500 | View SEC filing |
1-25 of 123